"EMEA" [European Agency for the Evaluation of Medical Products Pre-authorisation Evaluation for Human Use]
- Date:
- January 2003-December 2005
- Reference:
- PP/CNE/C/16
- Part of:
- Dr Claus Newman: archive
- Archives and manuscripts
About this work
Description
Correspondence with and about EMEA and consideration of potentially widening the licensing of thalidomide in the European Economic Community, Correspondence and papers about current licensing and marketing of thalidomide by different companies. Correspondence and papers regarding various groups working together to produce a risk management scheme for licensing thalidomide and co-ordination of the effort, including correspondence and papers from Thalidomide UK and the Thalidomide Society and a report on the Society's recommendations. One letter is in German and some papers are in Spanish.
Publication/Creation
January 2003-December 2005
Physical description
1 file
Terms of use
This item is restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2091.
Where to find it
Location Status Access Closed stores